Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
05/2012
05/31/2012WO2011158034A3 Coating compositions and methods of obtaining thereof
05/31/2012WO2011155800A9 Deacetylation hydrolase of hyaluronic acid, hyaluronic acid deacetylated by same and derivative thereof
05/31/2012WO2011148209A3 Use of diatomaceous earth in the pharmaceutical industry
05/31/2012WO2011135294A8 Method, device and system for targetted cell lysis
05/31/2012WO2011121034A3 Water-free pharmaceutical compositions suitable for local anaesthetics
05/31/2012WO2011111067A3 A biodegradable polymeric hydrogel composition
05/31/2012WO2011063776A3 Soluble beta-glucan-api complexes for pharmaceutical use
05/31/2012US20120136073 Amine-Containing Transfection Reagents and methods for making and using same
05/31/2012US20120136072 Sulfoalkyl Ether Cyclodextrin Compositions and Methods of Preparation Thereof
05/31/2012US20120136071 Medicinal Cream For Diaper Rash And A Process To Make It
05/31/2012US20120136070 Ketal esters of anhydropentitols and uses thereof
05/31/2012US20120136021 Oxidation-stabilized tamper-resistant dosage form
05/31/2012US20120135991 Orally rapidly disintegrating tablet that contains two or more types of particles
05/31/2012US20120135969 Novel powdered crystalline medicines for inhalation
05/31/2012US20120135924 Prosthesis for Joint Cartilage Repair and Method of Manufacture
05/31/2012US20120135922 Modified exendins and exendin agonists
05/31/2012US20120135065 Amphoteric Liposomes, A Method Of Formulating An Amphoteric Liposome And A Method Of Loading An Amphoteric Liposome
05/31/2012US20120135063 Glucuronic acid-containing glucan, process for production of same, and use of same
05/31/2012US20120135054 Poly (Ester Ether Amide)s and Uses Thereof
05/31/2012US20120135052 Method for preparing an organic-compatible and water-compatible composition of metal nanocrystals, and resulting composition
05/31/2012US20120134958 Hydroxyethyl starch-containing polypeptide compositions
05/31/2012US20120134956 Colloidal metal compositions and methods
05/31/2012US20120134950 Adhesion-Promoting thin Film and Moisture Resistant Skin Barrier Compositions
05/31/2012US20120134949 Polymeric collagen biomaterials
05/31/2012US20120134940 Nanodispersions
05/31/2012US20120134926 Charge-dynamic polymers and delivery of anionic compounds
05/31/2012US20120134925 Application and Uses of PRG4 and Therapeutic Modulation Thereof
05/31/2012US20120134917 Dermatological composition
05/31/2012US20120132204 Unit dose dry powder inhaler
05/31/2012CA2818894A1 Protein delivery from stem cell microcarriers
05/31/2012CA2818873A1 Stealth polymeric particles for delivery of bioactive or diagnostic agents
05/31/2012CA2818869A1 Biodegradable stealth polymeric particles fabricated using the macromonomer approach by free radical dispersion polymerization
05/31/2012CA2818671A1 Stable preserved compositions of interferon-beta
05/31/2012CA2818249A1 Pharmaceutical compositions
05/31/2012CA2817177A1 Fast disintegrating compositions comprising nabilone and randomly methylated beta cyclodextrin
05/31/2012CA2816288A1 Compositions of rotigotine, derivatives thereof, or pharmaceutically acceptable salts of rotigotine or its derivative
05/31/2012CA2816216A1 Binding drugs with nanocrystalline cellulose (ncc)
05/30/2012EP2457920A1 Oligosaccharides comprising an aminooxy group and conjugates thereof
05/30/2012EP2457919A1 Oligosaccharides comprising an aminooxy group and conjugates thereof
05/30/2012EP2457593A1 Cyclic RGD peptides of amino acids based on thiazoles or oxazoles as selective antagonists of the alpha-v beta-3 integrin
05/30/2012EP2457592A1 Microneedle array
05/30/2012EP2457591A2 Dendritic pic micelles with bioactive proteins
05/30/2012EP2457590A2 Protein formulation
05/30/2012EP2457587A1 Anitbodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
05/30/2012EP2457586A1 Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
05/30/2012EP2457570A1 Fentanyl-containing adhesive preparation for external use
05/30/2012EP2457566A1 EXTERNAL PREPARATION CONTAINING NSAIDs AND METHOD FOR PRODUCING THE EXTERNAL PREPARATION
05/30/2012EP2457561A1 Tablet having hollow structure
05/30/2012EP2457560A1 Topical compositions
05/30/2012EP2456471A2 Iron preparation suitable for pharmaceutical formulation and process for the preparation thereof
05/30/2012EP2456470A1 Delivery system and conjugates for compound delivery via naturally occurring intracellular transport routes
05/30/2012EP2456469A1 Oligomer-opioid agonist conjugates
05/30/2012EP2456468A1 Fas (apo-1, cd95) targeted platforms for intracellular drug delivery
05/30/2012EP2456467A1 -polylysine conjugates and use thereof
05/30/2012EP2456466A1 Adhesive complex coacervates and methods of making and using thereof
05/30/2012EP2456439A2 A stable pharmaceutical omeprazole formulation for oral administration
05/30/2012EP2456423A2 Treatment of hyperproliferative conditions
05/30/2012EP2456422A2 Topical pharmaceutical composition including rel-n-[6-[(2r,6s)-2,6-dimethyl-4-morpholinyl]-3-pyridinyl]-2-methyl-41-(trifluoromethoxy)-[1,1'-biphenyl]-3-carboxamide.
05/30/2012EP2456409A1 Natural preservative blend
05/30/2012EP1843783B1 Control of drug release by transient modification of local microenvironments
05/30/2012EP1558078B1 Acidified chlorite compositions containing nitrogenous stabilizers and systems and methods related thereto
05/30/2012EP1372619B1 Process for the production of a highly flexible transdermal therapeutic system having nicotine as active substance
05/30/2012EP1355673B1 Multivalent meningococcal polysaccharide-protein conjugate vaccine
05/30/2012EP1178808B1 Non-aqueous pharmaceutical composition for dermal use to treat psoriasis comprising a vitamin d, a corticosteroid and a solvent component
05/30/2012CN202236433U Blumea riparia tablet
05/30/2012CN1993144B Stable dosing form of phenylalanine derivatives
05/30/2012CN1951367B Fat emulsion containing hydroxycamptothecine and preparation method thereof
05/30/2012CN1655766B Sustained release of guaifenesin combination drugs
05/30/2012CN1615156B Preparation of resinates
05/30/2012CN102482685A 包括多核苷酸剂的细胞靶向纳米颗粒及其应用 Including cell polynucleotide agents targeted nanoparticle and its application
05/30/2012CN102482646A 幽门螺杆菌脂多糖外部核心表位 Helicobacter pylori lipopolysaccharide external core epitope
05/30/2012CN102482526A Coating agent comprising hydroxyalkyl cellulose
05/30/2012CN102482477A 水溶性聚合物组合物、皮肤贴剂的膏体层形成用组合物、及皮肤贴剂 A water-soluble polymer composition, the skin patch paste layer forming composition, and a skin patch
05/30/2012CN102482358A 羟丙基纤维素粒子 Hydroxypropyl cellulose particles
05/30/2012CN102482349A 抗vegf抗体和其用途 Anti-vegf antibodies and their use
05/30/2012CN102482324A Novel chemokine binding polypeptides capable of inhibiting the course of autoimmunity, inflammation and cancer
05/30/2012CN102481378A Hpv颗粒及其用途 Hpv particles and their use
05/30/2012CN102481377A 糖基化相关的材料和方法 Glycosylation-related materials and methods
05/30/2012CN102481376A Immunomodulatory agent-polymeric compounds
05/30/2012CN102481375A Nanocarriers possessing components with different rates of release
05/30/2012CN102481374A Nanocarriers possessing components with different rates of release
05/30/2012CN102481373A Drug fusions and conjugates
05/30/2012CN102481372A 作为增溶剂的单萜糖苷类及其组合 As a solubilizing monoterpene glycosides and combinations
05/30/2012CN102481371A 用于治疗家禽的粘性软质凝胶 For the treatment of poultry sticky soft gel
05/30/2012CN102481370A 聚合物药物传递系统及生产所述系统的方法 Polymeric drug delivery systems and production method of the system
05/30/2012CN102481367A Bi-specific digoxigenin binding antibodies
05/30/2012CN102481343A 稳定的含胰岛素的非水液体药物组合物 Stability of the insulin-containing non-aqueous liquid pharmaceutical composition
05/30/2012CN102481315A Antacid And Laxative Tablet
05/30/2012CN102481305A 磷脂酰胆碱的经皮组合物及其制备方法 Phosphatidylcholine percutaneous composition and its preparation method
05/30/2012CN102481301A 含有拉坦前列素的水性滴眼剂以及抑制拉坦前列素对树脂的吸附的方法 The method of water containing latanoprost latanoprost eye drops and inhibit the absorption of resin
05/30/2012CN102481296A 溶解性改善的药用组合物 Improved solubility of the pharmaceutical composition
05/30/2012CN102481286A 抗真菌药物组合物 Antifungal compositions
05/30/2012CN102481268A 眼科用组合物和白浊、沉淀的抑制方法 Ophthalmic compositions, and white turbidity, precipitation inhibiting
05/30/2012CN102481258A 源自固体粉末疏水化合物的薄膜包衣组合物 Film coating compositions derived from the solid powder of the hydrophobic compound
05/30/2012CN102481255A Particle composition and medicinal composition comprising same
05/30/2012CN102481254A Method and pharmaceutical compositions for trans-buccal mucosa treatment of postprandial hyperglycaemia in type ii diabetes
05/30/2012CN102481251A Ipamorelin diacetate injection and infusion solutions
05/30/2012CN102481249A 包含相对构型-n-[6-[(2r，6s)-2，6-二甲基-4-吗啉基]-3-吡啶基]-2-甲基-4'-(三氟甲氧基)-[1，1'-联苯]-3-甲酰胺的局部药物组合物 Contains the relative configuration -n- [6 - [(2r, 6s) -2,6- dimethyl-4-morpholinyl] -3-pyridinyl] -2-methyl-4 '- (trifluoromethyl oxy) - local drug [1,1'-biphenyl] -3-carboxamide composition
05/30/2012CN102480998A 赤藓醇和异麦芽酮糖醇的压片 Erythritol and isomalt alcohols tableting
05/30/2012CN102477439A 三元复合物和含有三元复合物的液体及制备方法与应用 Ternary complex and fluid, and preparation method and application containing ternary complexes
1 ... 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 ... 1712